How Type1Cure labels Type 1 diabetes evidence before it becomes a headline
The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.
Why labels matter
Families looking for Type 1 diabetes breakthroughs are exposed to a constant mix of legitimate science, company promotion, device updates, creator experience, and cure hype. Type1Cure needs to make the source class visible before the headline is allowed to carry emotional weight.
The site starts by keeping regulator, registry, peer-reviewed, nonprofit, company, media, and community sources in separate lanes. That prevents a viral post from being displayed as if it has the same clinical weight as an official trial record or FDA notice.
The practical ranking
- T0: official registries and regulators, including ClinicalTrials.gov and FDA databases.
- T1: peer-reviewed or indexed research, including PubMed and DOI records.
- T2-T3: nonprofit, institution, company, and press sources that may be useful but need context.
- T4-T5: media, social, podcast, creator, and community signals that can be valuable but cannot be treated as medical proof.
The rule for families
A source can be useful without being actionable. Type1Cure’s job is to surface it, label it, link it, and explain what question it raises. Treatment decisions still belong with licensed clinicians and the family care team.
This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.